SUBSCRIBE
SUBSCRIBE
News   Business

Genizon BioSciences Inc. Licenses Ingenuity Systems Pathways Analysis 3.0

October 26, 2005 | 
1 min read

Genizon BioSciences and Ingenuity today announced that they have entered into an agreement for the licensing of Ingenuity Pathways Analysis 3.0, significantly accelerating Genizon’s genes-to-targets process.

Alliances
MORE ON THIS TOPIC
Man making decision what path, direction to take. Arrows pointing in different directions
Business
Adaptimmune Raises ‘Substantial Doubt’ About Business Despite First-in-Class T Cell Therapy
March 21, 2025
 · 
2 min read
 · 
Tristan Manalac
medical bottles isolated on blue background, drugs and
Mergers & acquisitions
Paratek Broadens Portfolio With OptiNose Buy Worth up to $330M
March 20, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Pictured: Blue Sanofi sign on building in Germany at night
I&I
Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease
March 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Dollar banknote cut into pieces on a yellow background
Bankruptcy
Purdue Files for Bankruptcy Anew to Support $7.4B+ Opioid Settlement
March 20, 2025
 · 
2 min read
 · 
Tristan Manalac